UPDATE: Canaccord Upgrades Omeros; Raises PT - Omeros (NASDAQ:OMER)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

According to a research report published earlier today, Canaccord has upgraded Omeros Corp. (NASDAQ: OMER) from Hold to Buy, and has increased PT from $5 to $13.Canaccord commented in the report, “Upgrading to BUY from Hold, raising target to $13 from $5 on increased chance of OMS302 success in eye surgery. Phase 3 OMS302 is in trials for pupil dilation maintenance in lens surgery. 302 is the Omeros' second PharmacoSurgery asset after OMS103, in a Phase 3 meniscectomy knee surgery trial (data due Q3/12). We are raising our pNPV-based target from $5 to $13 on increased chances of OMS302 success from first Phase 3 data.”Omeros is currently trading at $10.35.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!